PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'From Public Health England (J.L.B., N.A., C.G., E.G., R.S., S.T., J.S., E.T., N.G., G.D., R.M., C.N.J.C., G.A., M.E., M.Z., K.E.B., S.H., M.C., M.R.), the National Institute of Health Research (NIHR) Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine (J.L.B., N.A., C.N.J.C., G.A., K.E.B., M.R.), the NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London (J.L.B., M.Z.), and Guy\'s and St. Thomas\' Hospital NHS Trust (M.C.), London, and Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford (S.H.) - all in the United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1056/NEJMoa2108891
?:doi
?:hasPublicationType
?:journal
  • The New England journal of medicine
is ?:pmid of
?:pmid
?:pmid
  • 34289274
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all